Gollob Jared

EDGAR CIK 0001821198

Kymera Therapeutics, Inc. - KYMR

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Officer
Chief Medical Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($174,786)
-5,740 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/03/2025
03/03/2025
Sell
-5,740 @ $30.45
 ($174,786) 120,000 (-4.56%) Direct